Index Catalog // Hyrax

Cancellare i filtri

Filtro per: Study Program Molecular Medicine Study Program (MolMed) Year 2024

PCSK9 Inhibition Enhances Efficacy of Vemurafenib in Delaying Melanoma Tumor Growth

Beta-blocker use and hematopoietic stem cell transplant outcomes